GREAT POINT PARTNERS LLC Quant / Systematic

Location: Greenwich, CT

CIK: 0001281446 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value: $1.251B (100.0% shares, 0.0% debt)

Holdings (36)

CONSTELLATION PHARMCETICLS I 8.4%
Value $105M Shares 3,480,000 Est. Cost $35.95 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 8.2%
Value $102M Shares 3,724,976 Est. Cost $18.15 Unrealized +81.1%
ZYMEWORKS INC 7.4%
Value $92.87M Shares 2,574,688 Est. Cost $8101.10 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 7.0%
Value $87.49M Shares 1,804,993 Est. Cost $29.42 Unrealized +63.2%
SAGE THERAPEUTICS INC 7.0%
Value $87.42M Shares 2,102,368 Est. Cost $46.88 Unrealized
ARENA PHARMACEUTICALS INC 6.6%
Value $81.99M Shares 1,302,399 Est. Cost $56.72 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 6.0%
Value $75.02M Shares 620,000 Est. Cost $85.03 Unrealized +32.3%
TGTX TG THERAPEUTICS INC 5.2%
Value $64.69M Shares 3,320,808 Est. Cost $9.56 Unrealized +68.5%
BIOHAVEN PHARMACTL HLDG CO L 4.9%
Value $61.48M Shares 840,900 Est. Cost $46.07 Unrealized
GW PHARMACEUTICALS PLC 4.4%
Value $55.22M Shares 450,000 Est. Cost $92.92 Unrealized
AKBA AKEBIA THERAPEUTICS INC 3.8%
Value $47.67M Shares 3,510,073 Est. Cost $10.35 Unrealized 0.0%
MGNX MACROGENICS INC 3.3%
Value $41.88M Shares 1,500,000 Est. Cost $17.37 Unrealized 0.0%
CYTK CYTOKINETICS INC 2.9%
Value $35.84M Shares 1,520,635 Est. Cost $15.87 Unrealized +18.1%
GLOBAL BLOOD THERAPEUTICS IN 2.7%
Value $34.23M Shares 542,200 Est. Cost $63.13 Unrealized
GERN GERON CORP 2.7%
Value $33.57M Shares 15,398,079 Est. Cost $1.49 Unrealized 0.0%
VCEL VERICEL CORP 1.8%
Value $22.25M Shares 1,610,154 Est. Cost $13.53 Unrealized 0.0%
PRTA PROTHENA CORP PLC 1.7%
Value $21.79M Shares 2,082,841 Est. Cost $10.02 Unrealized +10.9%
NEXTCURE INC 1.7%
Value $21.43M Shares 999,666 Est. Cost $53.71 Unrealized
ABEONA THERAPEUTICS INC 1.7%
Value $21.03M Shares 7,213,012 Est. Cost $2.82 Unrealized
GKOS GLAUKOS CORP 1.5%
Value $19.21M Shares 500,000 Est. Cost $37.23 Unrealized 0.0%
MOLECULAR TEMPLATES INC 1.5%
Value $18.55M Shares 1,345,397 Est. Cost $13.91 Unrealized
PTCT PTC THERAPEUTICS INC 1.3%
Value $16.74M Shares 330,000 Est. Cost $28.65 Unrealized +71.5%
AXONICS MODULATION TECHNOLOG 1.3%
Value $16.13M Shares 459,503 Est. Cost $27.39 Unrealized
SGMO SANGAMO THERAPEUTICS INC 1.1%
Value $14.16M Shares 1,579,891 Est. Cost $8.53 Unrealized +8.7%
CTMX CYTOMX THERAPEUTICS INC 1.0%
Value $12.07M Shares 1,448,604 Est. Cost $9.06 Unrealized +2.5%
CALITHERA BIOSCIENCES INC 1.0%
Value $11.94M Shares 2,261,700 Est. Cost $5.28 Unrealized
LQDA LIQUIDIA TECHNOLOGIES INC 0.9%
Value $10.76M Shares 1,277,955 Est. Cost $4.01 Unrealized +89.1%
ARVN ARVINAS INC 0.5%
Value $6.825M Shares 203,500 Est. Cost $29.28 Unrealized +45.0%
DNLI DENALI THERAPEUTICS INC 0.5%
Value $6.77M Shares 280,000 Est. Cost $23.51 Unrealized 0.0%
VRAYQ VIEWRAY INC 0.5%
Value $6.213M Shares 2,773,811 Est. Cost $3.08 Unrealized -30.7%
OYSTER PT PHARMA INC 0.5%
Value $6.199M Shares 214,631 Est. Cost $28.88 Unrealized
ACCELERON PHARMA INC 0.4%
Value $5.531M Shares 58,056 Est. Cost $18289.17 Unrealized
KADMON HLDGS INC 0.3%
Value $3.459M Shares 675,679 Est. Cost $5.12 Unrealized
MILLENDO THERAPEUTICS INC 0.2%
Value $2.571M Shares 1,460,697 Est. Cost $7.64 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 0.1%
Value $965K Shares 92,502 Est. Cost $10.35 Unrealized 0.0%
NEOLEUKIN THERAPEUTICS INC 0.0%
Value $233K Shares 14,065 Est. Cost $11.38 Unrealized